SITE013-0278

SITE013 (USA) › SITE013-0278

SITE013-0278

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE013 (USA) · Dr. Clarke
consented 2026-08-02

enrolled

AEs

1

Serious

1

Dropout signal

–

Adverse events

1

Grade 3 Asthenia — outcome: RECOVERED/RESOLVED; onset 2023-02-23 (study day 13); relationship: NOT RELATED; serious criteria: hospitalization

severe serious under_review

Data queries

0

No data queries. Open queries would appear here for this patient.